Abstract

BackgroundP. aeruginosa is a pathogen frequently resistant to antibiotics and a common cause of ventilator-associated pneumonia (VAP). Non-antibiotic strategies to prevent or treat VAP are therefore of major interest. Specific polyclonal avian IgY antibodies have previously been shown to be effective against pneumonia caused by P. aeruginosa in rodents and against P. aeruginosa airway colonization in patients.ObjectivesTo study the effect of specific polyclonal anti-P. aeruginosa IgY antibodies (Pa-IgY) on colonization of the airways in a porcine model.MethodThe pigs were anesthetized, mechanically ventilated, and subject to invasive hemodynamic monitoring and allocated to either receive 109 CFU nebulized P. aeruginosa (control, n = 6) or 109 CFU nebulized P. aeruginosa + 200 mg Pa-IgY antibodies (intervention, n = 6). Physiological measurement, blood samples, and tracheal cultures were then secured regularly for 27 h, after which the pigs were sacrificed and lung biopsies were cultured.ResultsAfter nebulization, tracheal growth of P. aeruginosa increased in both groups during the experiment, but with lower growth in the Pa-IgY-treated group during the experiment (p = 0.02). Tracheal growth was 4.6 × 103 (9.1 × 102–3.1 × 104) vs. 4.8 × 104 (7.5 × 103–1.4 × 105) CFU/mL in the intervention group vs. the control group at 1 h and 5.0 × 100 (0.0 × 100–3.8 × 102) vs. 3.3 × 104 (8.0 × 103–1.4 × 105) CFU/mL at 12 h in the same groups. During this time, growth in the intervention vs. control group was one to two orders of ten lower. After 12 h, the treatment effect disappeared and bacterial growth increased in both groups. The intervention group had lower body temperature and cardiac index and higher static compliance compared to the control group.ConclusionIn this porcine model, Pa-IgY antibodies lessen bacterial colonization of the airways.

Highlights

  • P. aeruginosa is a pathogen frequently resistant to antibiotics and a common cause of ventilator-associated pneumonia (VAP)

  • After nebulization, tracheal growth of P. aeruginosa increased in both groups during the experiment, but with lower growth in the P. aeruginosa IgY antibodies (Pa-IgY)-treated group during the experiment (p = 0.02)

  • The ability to harvest IgY from eggs laid by hens inoculated with P. aeruginosa provides a cheap and effective production method of specific polyclonal anti-P. aeruginosa IgY antibodies (Pa-IgY) [7]

Read more

Summary

Introduction

P. aeruginosa is a pathogen frequently resistant to antibiotics and a common cause of ventilator-associated pneumonia (VAP). Specific polyclonal avian IgY antibodies have previously been shown to be effective against pneumonia caused by P. aeruginosa in rodents and against P. aeruginosa airway colonization in patients. The ability to harvest IgY from eggs laid by hens inoculated with P. aeruginosa provides a cheap and effective production method of specific polyclonal anti-P. aeruginosa IgY antibodies (Pa-IgY) [7]. These antibodies bind primarily to the flagella of these bacteria and facilitate opsonization by augmenting the phagocytic activity of polymorphonuclear neutrophils [8]. No study has previously investigated the prophylactic properties of Pa-IgY in a model of VAP development

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.